These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33717255)

  • 1. Novel immunological and genetic factors associated with vitiligo: A review.
    Said-Fernandez SL; Sanchez-Domínguez CN; Salinas-Santander MA; Martinez-Rodriguez HG; Kubelis-Lopez DE; Zapata-Salazar NA; Vazquez-Martinez OT; Wollina U; Lotti T; Ocampo-Candiani J
    Exp Ther Med; 2021 Apr; 21(4):312. PubMed ID: 33717255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.
    Dwivedi M; Laddha NC; Begum R
    Adv Exp Med Biol; 2022; 1367():61-103. PubMed ID: 35286692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Different Genes Expressions during Immunological and Inflammatory Responses in Vitiligo.
    Sharma CK; Sharma M; Prasad K
    Crit Rev Eukaryot Gene Expr; 2017; 27(3):277-287. PubMed ID: 29199612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine vitiligo-like depigmentation in grey horses is related to genes involved in immune response and tumor metastasis.
    Druml T; Brem G; Velie B; Lindgren G; Horna M; Ricard A; Grilz-Seger G
    BMC Vet Res; 2021 Oct; 17(1):336. PubMed ID: 34696794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular basis of depigmentation in vitiligo patients.
    Delmas V; Larue L
    Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
    Yu HS
    J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological differences between vitiligo and lichen sclerosus et atrophicus using quantitative immunohistochemical analysis.
    Park YJ; Lee H; Park HS; Kim YC
    Front Med (Lausanne); 2023; 10():1205909. PubMed ID: 37521337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo: a manifestation of apoptosis?
    Huang CL; Nordlund JJ; Boissy R
    Am J Clin Dermatol; 2002; 3(5):301-8. PubMed ID: 12069635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into the role of exosomes in vitiligo.
    Wong PM; Yang L; Yang L; Wu H; Li W; Ma X; Katayama I; Zhang H
    Autoimmun Rev; 2020 Nov; 19(11):102664. PubMed ID: 32942029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Activities in Choroids of Visually Impaired Smyth Chickens With Autoimmune Vitiligo.
    Sorrick J; Huett W; Byrne KA; Erf GF
    Front Med (Lausanne); 2022; 9():846100. PubMed ID: 35547230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo.
    Chaudhary A; Patel M; Singh S
    Curr Drug Targets; 2022; 23(13):1219-1238. PubMed ID: 35388753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depigmentation of the skin induced by 4-(4-hydroxyphenyl)-2-butanol is spontaneously re-pigmented in brown and black guinea pigs.
    Kuroda Y; Takahashi Y; Sakaguchi H; Matsunaga K; Suzuki T
    J Toxicol Sci; 2014 Aug; 39(4):615-23. PubMed ID: 25056786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Therapy Offers a Possible Safe and Promising Alternative Approach for Treating Vitiligo: A Review.
    Esquivel D; Mishra R; Srivastava A
    Curr Pharm Des; 2020; 26(37):4815-4821. PubMed ID: 32744962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.